|
Volumn 51, Issue 1, 2005, Pages 33-35
|
Neuroendocrine differentiation in adenocarcinoma of prostate during combined androgen blockade therapy: A case report
a a a a a a a |
Author keywords
Neuroendocrine carcinoma; Neuroendocrine differentiation; Prostatic carcinoma
|
Indexed keywords
ANDROGEN RECEPTOR;
ANTIANDROGEN;
CHROMOGRANIN A;
CISPLATIN;
CORTICOTROPIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
NERVE CELL ADHESION MOLECULE;
PROSTATE SPECIFIC ANTIGEN;
SYNAPTOPHYSIN;
THYROTROPIN;
VASOPRESSIN;
VINCRISTINE;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER HORMONE THERAPY;
CANCER STAGING;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
MALE;
NEUROENDOCRINE TUMOR;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OUTCOMES RESEARCH;
PROGNOSIS;
PROSTATE ADENOCARCINOMA;
TUMOR BIOPSY;
TUMOR DIFFERENTIATION;
ADENOCARCINOMA;
CARCINOMA;
CELL TRANSFORMATION;
DRUG RESISTANCE;
PATHOLOGY;
PROSTATE TUMOR;
ADENOCARCINOMA;
AGED;
AGED, 80 AND OVER;
ANDROGEN ANTAGONISTS;
CARCINOMA, NEUROENDOCRINE;
CELL TRANSFORMATION, NEOPLASTIC;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MALE;
NEOPLASM STAGING;
PROSTATIC NEOPLASMS;
|
EID: 14144251532
PISSN: 00181994
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (10)
|